sunitinib malate Latest Research Papers

Investigation of temperature-responsive tocosomal nanocarriers as the efficient and robust drug delivery system for Sunitinib malate anti-cancer drug: Effects of MW and chain length of PNIPAAm on LCST and dissolution rate

Journal of Pharmaceutical Sciences ◽

10.1016/j.xphs.2021.12.022 ◽

2021 ◽

Author(s):

Fariba Razmimanesh ◽

Gholamhossein Sodeifian

Keyword(s):

Drug Delivery ◽

Dissolution Rate ◽

Drug Delivery System ◽

Chain Length ◽

Delivery System ◽

Drug Effects ◽

Cancer Drug ◽

Sunitinib Malate ◽

Temperature Responsive ◽

Anti Cancer

A Phase II Study Evaluating the Safety and Efficacy of Sunitinib Malate in Combination with Weekly Paclitaxel Followed by Doxorubicin and Daily Oral Cyclophosphamide Plus G-CSF as Neoadjuvant Chemotherapy for Locally Advanced or Inflammatory Breast Cancer

Clinical Breast Cancer ◽

10.1016/j.clbc.2021.05.009 ◽

2021 ◽

Author(s):

LK Symonds ◽

I Jenkins ◽

HM Linden ◽

B Kurland ◽

JR Gralow ◽

...

Keyword(s):

Breast Cancer ◽

Neoadjuvant Chemotherapy ◽

Phase Ii ◽

Inflammatory Breast Cancer ◽

Phase Ii Study ◽

Locally Advanced ◽

Weekly Paclitaxel ◽

Oral Cyclophosphamide ◽

Sunitinib Malate ◽

Safety And Efficacy

An investigation into Sunitinib malate nanoparticle production by US- RESOLV method: Effect of type of polymer on dissolution rate and particle size distribution

The Journal of Supercritical Fluids ◽

10.1016/j.supflu.2021.105163 ◽

2021 ◽

Vol 170 ◽

pp. 105163

Author(s):

Fariba Razmimanesh ◽

Gholamhossein Sodeifian ◽

Seyed Ali Sajadian

Keyword(s):

Particle Size ◽

Particle Size Distribution ◽

Dissolution Rate ◽

Size Distribution ◽

Sunitinib Malate ◽

Nanoparticle Production ◽

Method Effect

Effective Antiviral Activity of the Tyrosine Kinase Inhibitor Sunitinib Malate against Zika Virus

Infection and Chemotherapy ◽

10.3947/ic.2021.0111 ◽

2021 ◽

Vol 53 ◽

Author(s):

Chen-Sheng Lin ◽

Su-Hua Huang ◽

Bo-Yu Yan ◽

Hsueh-Chou Lai ◽

Cheng-Wen Lin

Keyword(s):

Antiviral Activity ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Zika Virus ◽

Kinase Inhibitor ◽

Sunitinib Malate

Analysis of Sunitinib Malate, A Multi-targeted Tyrosine Kinase Inhibitor: A Critical Review

Microchemical Journal ◽

10.1016/j.microc.2021.105926 ◽

2021 ◽

pp. 105926

Author(s):

Asmaa M. AboulMagd ◽

Nada S. Abdelwahab

Keyword(s):

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Critical Review ◽

Kinase Inhibitor ◽

Sunitinib Malate

Sunitinib malate inhibits hemangioma cell growth and migration by suppressing focal adhesion kinase signaling

Journal of Applied Biomedicine ◽

10.32725/jab.2020.019 ◽

2020 ◽

Vol 18 (4) ◽

pp. 143-151

Author(s):

Wihan Scholtz ◽

Peace Mabeta

Keyword(s):

Cell Growth ◽

Focal Adhesion Kinase ◽

Focal Adhesion ◽

Kinase Signaling ◽

Cell Growth And Migration ◽

Sunitinib Malate ◽

And Migration ◽

Focal Adhesion Kinase Signaling

Sunitinib malate-loaded biodegradable microspheres for the prevention of corneal neovascularization in rats

Journal of Controlled Release ◽

10.1016/j.jconrel.2020.08.019 ◽

2020 ◽

Vol 327 ◽

pp. 456-466 ◽

Cited By ~ 1

Author(s):

Jin Yang ◽

Lixia Luo ◽

Yumin Oh ◽

Tuo Meng ◽

Guihong Chai ◽

...

Keyword(s):

Corneal Neovascularization ◽

Biodegradable Microspheres ◽

Sunitinib Malate

Sunitinib malate inhibits intestinal tumor development in male ApcMin/+ mice by down-regulating inflammation-related factors with suppressing β-cateinin/c-Myc pathway and re-balancing Bcl-6 and Caspase-3

International Immunopharmacology ◽

10.1016/j.intimp.2020.107128 ◽

2020 ◽

pp. 107128

Author(s):

Lai Chen ◽

Pan Xu ◽

Qiuping Xiao ◽

Liling Chen ◽

Shanshan Li ◽

...

Keyword(s):

Caspase 3 ◽

Tumor Development ◽

Intestinal Tumor ◽

Related Factors ◽

Sunitinib Malate

Preferential solvation and solvation shell composition of sunitinib malate, an anti-tumor compound, in some binary mixed solvents at 298.15 K

Chemical Papers ◽

10.1007/s11696-020-01367-z ◽

2020 ◽

Author(s):

Mohsen Padervand ◽

Shima Naseri ◽

Sima Hajiahmadi

Keyword(s):

Preferential Solvation ◽

Mixed Solvents ◽

Solvation Shell ◽

Sunitinib Malate ◽

Shell Composition

Sodium alginate-halloysite nanotube gel beads as potential delivery system for sunitinib malate anticancer compound

Materials Letters ◽

10.1016/j.matlet.2020.128038 ◽

2020 ◽

Vol 274 ◽

pp. 128038 ◽

Cited By ~ 2

Author(s):

Ali Akbari ◽

Mohsen Padervand ◽

Elham Jalilian ◽

Farzad Seidi

Keyword(s):

Sodium Alginate ◽

Delivery System ◽

Halloysite Nanotube ◽

Sunitinib Malate ◽

Gel Beads ◽

Anticancer Compound

sunitinib malate
Recently Published Documents

TOTAL DOCUMENTS

H-INDEX

Investigation of temperature-responsive tocosomal nanocarriers as the efficient and robust drug delivery system for Sunitinib malate anti-cancer drug: Effects of MW and chain length of PNIPAAm on LCST and dissolution rate

A Phase II Study Evaluating the Safety and Efficacy of Sunitinib Malate in Combination with Weekly Paclitaxel Followed by Doxorubicin and Daily Oral Cyclophosphamide Plus G-CSF as Neoadjuvant Chemotherapy for Locally Advanced or Inflammatory Breast Cancer

An investigation into Sunitinib malate nanoparticle production by US- RESOLV method: Effect of type of polymer on dissolution rate and particle size distribution

Effective Antiviral Activity of the Tyrosine Kinase Inhibitor Sunitinib Malate against Zika Virus

Analysis of Sunitinib Malate, A Multi-targeted Tyrosine Kinase Inhibitor: A Critical Review

Sunitinib malate inhibits hemangioma cell growth and migration by suppressing focal adhesion kinase signaling

Sunitinib malate-loaded biodegradable microspheres for the prevention of corneal neovascularization in rats

Sunitinib malate inhibits intestinal tumor development in male ApcMin/+ mice by down-regulating inflammation-related factors with suppressing β-cateinin/c-Myc pathway and re-balancing Bcl-6 and Caspase-3

Preferential solvation and solvation shell composition of sunitinib malate, an anti-tumor compound, in some binary mixed solvents at 298.15 K

Sodium alginate-halloysite nanotube gel beads as potential delivery system for sunitinib malate anticancer compound

Export Citation Format

sunitinib malateRecently Published Documents

TOTAL DOCUMENTS

H-INDEX

Investigation of temperature-responsive tocosomal nanocarriers as the efficient and robust drug delivery system for Sunitinib malate anti-cancer drug: Effects of MW and chain length of PNIPAAm on LCST and dissolution rate

A Phase II Study Evaluating the Safety and Efficacy of Sunitinib Malate in Combination with Weekly Paclitaxel Followed by Doxorubicin and Daily Oral Cyclophosphamide Plus G-CSF as Neoadjuvant Chemotherapy for Locally Advanced or Inflammatory Breast Cancer

An investigation into Sunitinib malate nanoparticle production by US- RESOLV method: Effect of type of polymer on dissolution rate and particle size distribution

Effective Antiviral Activity of the Tyrosine Kinase Inhibitor Sunitinib Malate against Zika Virus

Analysis of Sunitinib Malate, A Multi-targeted Tyrosine Kinase Inhibitor: A Critical Review

Sunitinib malate inhibits hemangioma cell growth and migration by suppressing focal adhesion kinase signaling

Sunitinib malate-loaded biodegradable microspheres for the prevention of corneal neovascularization in rats

Sunitinib malate inhibits intestinal tumor development in male ApcMin/+ mice by down-regulating inflammation-related factors with suppressing β-cateinin/c-Myc pathway and re-balancing Bcl-6 and Caspase-3

Preferential solvation and solvation shell composition of sunitinib malate, an anti-tumor compound, in some binary mixed solvents at 298.15 K

Sodium alginate-halloysite nanotube gel beads as potential delivery system for sunitinib malate anticancer compound

sunitinib malate
Recently Published Documents